Mao-Lin Yan

机构：Fujian Medical University, Fujian Provincial People's Hospital, Fujian Provincial Hospital · ORCID：0000-0002-9852-2661

发表论文 98 篇 · 总被引 1247 次 · h-index 20

代表论文

• Transarterial chemoembolization plus atezolizumab and bevacizumab in patients with intermediate hepatocellular carcinoma: a single-arm, phase 2 trial (2025 · Signal Transduction and Targeted Therapy · 被引 14)
• Efficacy of Lenvatinib Combined with Anti–PD-1 Antibodies Plus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective, Multicenter Study (2024 · Cancer Research and Treatment · 被引 10)
• Prognostic Value of Clinical Complete Response for Patients with Initially Unresectable Hepatocellular Carcinoma after Conversion with Triple Therapy (2025 · Liver Cancer · 被引 6)
• Prognostic Value of the SII-PNI Score in Unresectable HCC Treated with Transcatheter Arterial Chemoembolization Combined with Lenvatinib and PD-1 Inhibitors (2025 · Journal of Inflammation Research · 被引 4)
• Trehalose metabolism contributed to abiotic stress tolerance of Larix gmelinii seedlings (2025 · Plant Physiology and Biochemistry · 被引 3)
• Efficacy and Safety of Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Inhibitors for Hepatocellular Carcinoma Patients with Extrahepatic Metastases: A Multicenter Retrospective Study (2024 · Journal of Hepatocellular Carcinoma · 被引 3)